What should you know about Condylox and imiquimod?

Condylox is a topical medicine that directly damages wart tissue when used exactly as prescribed. Imiquimod works by stimulating a local immune response in the treated skin. Neither medicine should be applied to every bump in the genital area, because several conditions can resemble a wart.

These treatments are intended for external areas specified by a clinician. They are not interchangeable, and using extra product or combining them without instructions can cause significant irritation. A clinician will consider pregnancy, broken skin, immune conditions, other medicines, and the number and position of lesions before recommending an option.

Follow the exact label and clinician instructions for where, when, and how much to apply. Wash your hands before and after use, keep treatment away from the eyes and mouth, and do not cover the area unless instructed. Avoid sexual contact while medicine is present or while the skin is sore; these products may not prevent transmission and may weaken barrier protection.

Mild redness, burning, peeling, or tenderness can occur at the treatment site. Do not apply more often to speed the result. If the reaction is severe, pause and contact the prescriber for advice rather than trying to neutralise it with another product.

Contact your clinician for intense pain, open sores, marked swelling, pus, fever, spreading rash, or difficulty passing urine. Seek review if lesions bleed, change appearance, recur quickly, or do not respond as expected. A new or unusual genital growth needs assessment rather than self-treatment.

Ask which medicine fits the diagnosed lesions, how to mark the treatment area, what reaction is expected, when to stop or restart after irritation, how partners should be informed, and when a follow-up examination is needed.